We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis' Reclast Approved for Postmenopausal Osteoporosis
Novartis' Reclast Approved for Postmenopausal Osteoporosis
August 24, 2007
The FDA has approved Novartis’ Reclast as the first once-yearly treatment for postmenopausal osteoporosis, the company announced Aug. 18.